Predicting outcome after initial relapse of epithelial ovarian cancer: Can we identify patients who will not benefit from further therapy?

CME Journal of Gynecologic Oncology

Volumn 4, Issue 1, 1999, Pages 64-68

  Hoskins, P J ^a   Eisenhauer, E A ^a   Van Glabbeke, M ^a   Vermorken, J B ^a   Tu, D ^a   James, K ^a  

^a Vancouver Cancer Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; GEMCITABINE; IRINOTECAN; PACLITAXEL;

CANCER CHEMOTHERAPY; CANCER RECURRENCE; FEMALE; HUMAN; OVARY CANCER; REVIEW; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0033336446     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)